BioLife Solutions Inc
NASDAQ:BLFS
BioLife Solutions Inc
NASDAQ:BLFS
Price:
19.54 USD
8.5%
Market Closed
Updated:
May 13, 2024
Balance Sheet
Balance Sheet Decomposition
BioLife Solutions Inc
BioLife Solutions Inc
| Current Assets | 120.6m |
| Cash & Short-Term Investments | 35.4m |
| Receivables | 18.7m |
| Other Current Assets | 66.5m |
| Non-Current Assets | 292.1m |
| Long-Term Investments | 5.1m |
| PP&E | 40.3m |
| Intangibles | 245.9m |
| Other Non-Current Assets | 821k |
| Current Liabilities | 42.2m |
| Accounts Payable | 6.9m |
| Accrued Liabilities | 19.5m |
| Other Current Liabilities | 15.7m |
| Non-Current Liabilities | 32.9m |
| Long-Term Debt | 19.5m |
| Other Non-Current Liabilities | 13.4m |
Balance Sheet
BioLife Solutions Inc
BioLife Solutions Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
2
|
1
|
7
|
31
|
6
|
90
|
70
|
19
|
35
|
|
| Cash Equivalents |
3
|
2
|
1
|
7
|
31
|
6
|
90
|
70
|
19
|
35
|
|
| Short-Term Investments |
7
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
3
|
5
|
8
|
23
|
34
|
19
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
3
|
5
|
8
|
23
|
34
|
19
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
2
|
2
|
2
|
4
|
11
|
12
|
28
|
35
|
43
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
5
|
5
|
50
|
23
|
|
| Total Current Assets |
12
|
7
|
5
|
10
|
38
|
24
|
115
|
126
|
139
|
121
|
|
| PP&E Net |
2
|
1
|
1
|
1
|
1
|
11
|
25
|
47
|
48
|
40
|
|
| PP&E Gross |
2
|
1
|
1
|
1
|
1
|
11
|
25
|
47
|
48
|
40
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
2
|
2
|
3
|
4
|
9
|
14
|
16
|
|
| Intangible Assets |
2
|
4
|
0
|
0
|
0
|
22
|
31
|
152
|
32
|
21
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
34
|
58
|
225
|
225
|
225
|
|
| Long-Term Investments |
0
|
0
|
2
|
1
|
7
|
3
|
6
|
4
|
5
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
34
|
58
|
225
|
225
|
225
|
|
| Total Assets |
16
N/A
|
12
-23%
|
8
-36%
|
12
+53%
|
46
+276%
|
93
+104%
|
235
+153%
|
554
+136%
|
450
-19%
|
413
-8%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
3
|
4
|
15
|
15
|
7
|
|
| Accrued Liabilities |
1
|
1
|
0
|
1
|
1
|
4
|
5
|
11
|
16
|
20
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
7
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
6
|
15
|
11
|
9
|
|
| Total Current Liabilities |
1
|
2
|
1
|
2
|
2
|
8
|
16
|
43
|
45
|
42
|
|
| Long-Term Debt |
0
|
0
|
3
|
0
|
0
|
0
|
1
|
7
|
24
|
19
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
|
| Minority Interest |
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
29
|
42
|
13
|
21
|
17
|
13
|
|
| Total Liabilities |
4
N/A
|
4
-9%
|
5
+23%
|
2
-56%
|
31
+1 367%
|
49
+60%
|
30
-40%
|
76
+157%
|
86
+13%
|
75
-13%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
60
|
64
|
71
|
74
|
98
|
100
|
97
|
107
|
247
|
313
|
|
| Additional Paid In Capital |
72
|
73
|
74
|
84
|
113
|
144
|
303
|
585
|
612
|
651
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
12
N/A
|
9
-28%
|
3
-62%
|
10
+216%
|
15
+45%
|
44
+198%
|
205
+372%
|
478
+133%
|
364
-24%
|
338
-7%
|
|
| Total Liabilities & Equity |
16
N/A
|
12
-23%
|
8
-36%
|
12
+53%
|
46
+276%
|
93
+104%
|
235
+153%
|
554
+136%
|
450
-19%
|
413
-8%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
12
|
12
|
13
|
14
|
19
|
21
|
33
|
42
|
43
|
45
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
